Samar A. Hegazy

IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma

Jennifer Dien Bard, Pascal Gélébart, Mona Anand et al. · American Journal Of Pathology · 2009 · 57 citations · Full text

Veterinary Medicine, Cell Biology, Oncology +12

Genetic Screening for Synthetic Lethal Partners of Polynucleotide Kinase/Phosphatase: Potential for Targeting SHP-1–Depleted Cancers

Todd R. Mereniuk, Robert A. Maranchuk, Anja Schindler et al. · Cancer Research · 2012 · 39 citations

Life Sciences, Molecular Biology, Oncology +17

Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma

Pascal Gélébart, Samar A. Hegazy, P Wang et al. · Blood Cancer Journal · 2012 · 37 citations · Full text

Medicine, Cell Biology, Oncology +17

Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis

Samir Al Bashir, Mohammed Alshalalfa, Samar A. Hegazy et al. · Journal of Hematology & Oncology · 2014 · 31 citations · Full text

Medicine, Oncology, Urology +17

Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification

Tarek A. Bismar, Samar A. Hegazy, Zhaoyong Feng et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 31 citations · Full text

Medicine, Oncology, Urology +16